WHO ICTRP trial
Combined multi-omics analysis study of markers for early screening and diagnosis…
ChiCTR2500097541 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500097541 |
|---|---|
| Public title | Combined multi-omics analysis study of markers for early screening and diagnosis of urologic tumors |
| Scientific title | Combined multi-omics analysis study of markers for early screening and diagnosis of urologic tumors |
| Primary sponsor | Cancer hospital Chinese Academy of Medical sciences, Shenzhen center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Countries | China |
| Conditions | Bladder cancer |
| Interventions | Gold Standard:Cystoscopy;Index test:Mutation detection, methylation site detection, customized MRD monitoring |
| Registration date | Feb 20, 2025 |
| Target size | Target condition:170;Difficult condition:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: